Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis | Cancer Cell International | Full Text
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition
Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition
A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect
Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition
Results of the meta-analysis of the diagnostic markers for colorectal... | Download Table
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology | SpringerLink
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
PDF) Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study | Modern Pathology
High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer | Scientific Reports
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma | British Journal of Cancer
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Colorectal cancer biomarkers | Abcam
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
